Medical Equipment

Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent

MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility ofMagSense® HER2 Imaging Agent (MSH2IA) as an adju...

2023-12-13 19:00 1669

Illumina partners with HaploX to build a domestically produced flagship benchtop sequencing system

SHENZHEN, China, Dec. 12, 2023 /PRNewswire/ -- On December 9, Illumina, a global leader in DNA sequencing and array-based technologies, and HaploX, aChina -based high-tech company specializing in oncology liquid biopsy and genetic big data, jointly announced the official launch of the first NextSe...

2023-12-12 17:31 1973

ICP DAS - BMP's Medical-Grade TPU Takes Center Stage at Top Global Medical & Plastic Exhibitions

HSINCHU, Dec. 12, 2023 /PRNewswire/ -- ICP DAS (3577-TW) New Business Unit, ICP DAS – BMP, actively ramps up medical-grade TPU (thermoplastic polyurethane) development and production as well as international marketing. The company's participation at COMPAMED and IPF Japan has been a resounding su...

2023-12-12 16:51 1869

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

* After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation inAustralia's BreastScreen NSW Machine Reading Solution Project SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therape...

2023-12-11 22:30 1442

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023

* This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of at least 12 months) with tumors harboring ESR1 mutations. * This analysis shows a clinically meaningful improvement in progression-free survivala...

2023-12-08 23:13 3320

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

TOKYO, Dec. 8, 2023 /PRNewswire/ -- According to Estimation of the Number of Patients With Mitochondrial Diseases: A Descriptive Study Using in a nationwide database inJapan , 2.9 out of every 100,000 people inJapan ...

2023-12-08 13:40 1646

Full-Life Technologies Breaks Ground for GMP Manufacturing Facility in Belgium to Advance Its End-to-end Solution for Radiopharmaceuticals

GEMBLOUX, Belgium, Dec. 7, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the construction of its new Good Manufacturing Practices (GMP) compliant manufacturing facility in Gembloux,Belgium, for radiopharmaceuticals. ...

2023-12-08 10:00 1239

Unlocking the Potential of Multi-Omics in Precision Medicine: A Conversation with Kazusa DNA Research Institute

CHIBA, Japan, Dec. 7, 2023 /PRNewswire/ -- The integration of multi-omics approaches offers a comprehensive panorama for advancing our comprehension of biology. It now plays a more important role in understanding the roots of diseases, and in expediting precision medicine and catalyzing advanceme...

2023-12-07 15:37 1585

Medtec China 2024 will be held on September 25-27, 2024, in Shanghai, China

SHANGHAI, Dec. 7, 2023 /PRNewswire/ -- According to the report on the  Development Status and Trends of Medical Device Industry inChina released by Roland Berger, an international management consulting firm, the market size of the medical device market inChina by 2030 is expected to exceed 2,200 b...

2023-12-07 00:00 1719

Micro Medical Solutions Announces Completion of Enrollment in the STAND Pivotal Clinical Trial

Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee, NCT03477604). WILMINGTON, Mass., Dec. 6, 2023 /PRNewswire/ -- Micro Medical Solut...

2023-12-06 21:32 1611

SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability

CAMARILLO, Calif., Dec. 6, 2023 /PRNewswire/ -- SaniSure, a global player in single-use bioprocessing solutions (drug substance and drug product form & fill) and cell & gene therapy is proud to announce that it has been awarded the EcoVadis Silver Rating for its sustainability practices. This rec...

2023-12-06 20:30 1699

GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia

* To commence operation by 2027…with max. 400K liters of plasma production capacity per annum * The first step towards localization of Indonesia's critical medical product YONGIN,South Korea, Dec. 5, 2023 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, announced onDece...

2023-12-06 08:56 1422

The 2023 Investor Open Day of Zylox-Tonbridge was successfully held

HANGZHOU, China, Dec. 5, 2023 /PRNewswire/ -- On November 29th, the 2023 Investor Open Day of Zylox-Tonbridge ("2190. HK", hereinafter referred to as "the Company") was successfully held in Hangzhou, China. The event attracted more than 200 online and offline investors and securities analysts wo...

2023-12-05 22:22 3817

inQB8 Medical Technologies LLC and Peijia Medical Limited Report Successful First-in-Human (FIH) Implantation of MonarQ Transcatheter Tricuspid Valve Replacement (TTVR) System in The United States of America

WINCHESTER, Mass. and SUZHOU, China, Dec. 5, 2023 /PRNewswire/ -- inQB8 Medical Technologies LLC (inQB8), in partnership with Peijia Medical Limited (Peijia, (9996.HK)),announced that it has successfully implanted the MonarQ Transcatheter Tricuspid Valve (TTV) in a patient suffering from torrenti...

2023-12-05 21:00 1330

Pioneering health innovations at China Int'l Supply Chain Expo

BEIJING, Dec. 4, 2023 /PRNewswire/ -- This is a report from China.org.cn about health innovations at China Int'l Supply Chain Expo:   At a dental clinic at the China Int'l Supply Chain Expo, you can take advantage of a free dental check. The 360° view allows you to see all a...

2023-12-04 22:20 1139

The 3rd International Medical Innovation and Cooperation Forum convenes in Fangchenggang

Enhancing Global Medical Collaboration and Advancing Shared Development through Inclusive Exchange BEIJING, Dec. 4, 2023 /PRNewswire/ -- On 26 November, the 3rd International Medical Innovation and Cooperation Forum was held in Fangchenggang, Guangxi Zhuang Autonomous Region,China. The forum, ...

2023-12-04 08:59 1731

Media Tour Witnesses Chinese Modernization in Hainan FTP

HAIKOU, China, Dec. 3, 2023 /PRNewswire/ -- From November 27 to December 1, a group made up of more than 60 reporters, overseas communication officers, and social media personalities got their chance to witness the development of the Hainan Free Trade Port (FTP) up close, as they visited key indu...

2023-12-03 16:07 4023

Bushu Pharma Recognized with Frost & Sullivan's 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing and Robust Supply Chain Solutions

Bushu Pharma produces high-quality pharmaceutical and medical devices with sophisticated quality control and supply chain management support that prioritizes customer value. SAN ANTONIO, Nov. 30, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the contract development and manufacturing...

2023-11-30 22:30 1391

Argon Medical Launches Kodiak™ Dual Port Coaxial Introducer Kit for Complex Vascular Procedures

PLANO, Texas, Nov. 30, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, announced the launch of the Kodiak™  Dual Port Coaxial Introducer Kit for precise and streamlined intro...

2023-11-30 22:22 1485

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

* Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through AimSG, a national medical imaging AI platform for Singapore's Public Healthcare SEOUL, South Korea, Nov. 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions fo...

2023-11-30 22:10 1595
1 ... 78910111213 ... 143